Optimizing Revenue Cycle Management in Oncology Practices: Key Strategies and Challenges for 2026
Oncology RCM faces high-cost drugs, prior auth hurdles, and ASP changes in 2026. Learn strategies to master coding, reduce denials, and accelerate collections.
Oncology billing remains one of healthcare’s toughest arenas: expensive biologics/infusions (often $10K+ per dose), intricate HCPCS/J-codes, frequent prior Auths, and strict documentation for medical necessity. 2026 brings added pressure from CMS ASP reporting updates, radiation code overhauls, and rising denials (up to 15–25% in specialty practices).
Major Challenges in 2026:
– Prior authorizations for chemo, radiation, and targeted therapies delays disrupt care and cash flow.
– Complex drug coding (e.g., new biosimilars, administration fees) and annual changes.
– Patient financial toxicity high copays lead to bad debt.
– Documentation gaps causing underpayments or audits.
Proven Optimization Strategies:
– Implement real-time eligibility verification and benefits checks at intake.
– Use dedicated prior-auth teams with payer-specific trackers.
– Conduct regular coding audits with updated guidelines.
– Offer financial counseling + copay assistance navigation.
– Track denials by root cause (e.g., missing auth) and appeal systematically.
– Leverage AI for predictive denial flagging on high-value claims.
Practices adopting these drop denials below 5–7% and improve net collections 20%+. Our battle-tested experts (15–20+ years in oncology/hematology) specialize in these leaks we uncover hidden underpayments and deliver fast uplifts.
Stop oncology revenue erosion. Get your free leakage assessment today.